/ Not yet recruitingPhase 1IIT A randomized, double-blind, placebo-controlled Phase I clinical study to evaluate the safety, tolerability, pharmacokinetics and preliminary efficacy of SA1211 injection in healthy volunteers and participants with chronic hepatitis B
100 Clinical Results associated with Hangzhou Shi'an Yuantai Biotechnology Co., Ltd.
0 Patents (Medical) associated with Hangzhou Shi'an Yuantai Biotechnology Co., Ltd.
100 Deals associated with Hangzhou Shi'an Yuantai Biotechnology Co., Ltd.
100 Translational Medicine associated with Hangzhou Shi'an Yuantai Biotechnology Co., Ltd.